Magellan Health (MGLN) Misses Q1 EPS by 20c

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.81, $0.20 worse than the analyst estimate of $1.01. Revenue for the quarter came in at $1.81 billion versus the consensus estimate of $1.83 billion.

GUIDANCE:

Magellan Health sees FY2018 EPS of $5.90-$6.68, versus the consensus of $6.71.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Vireo Growth completes acquisition of C21 Investments